Cookies?
Library Header Image
LSE Research Online LSE Library Services

Items where Subject is "R Medicine > RS Pharmacy and materia medica"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items at this level: 197.

A

Alkazemi, Mariam (2018) Regulation of healthcare advertisements: comparing media regulation of the pharmaceutical industry in Kuwait and the GCC. LSE Middle East Centre papers series (23). LSE Middle East Centre, London, UK.

Anderson, Michael, Naci, Huseyin, Morrison, Deborah, Osipenko, Leeza and Mossialos, Elias (2018) A review of NICE appraisals of pharmaceuticals 2000-2016 found variation in establishing comparative clinical effectiveness. Journal of Clinical Epidemiology. ISSN 0895-4356

Angelis, Aris (2018) Evaluating the benefits of new drugs in health technology assessment using multiple criteria decision analysis: a case study on metastatic prostate cancer with the dental and pharmaceuticals benefits agency (TLV) in Sweden. Medical Decision Making: Policy and Practice, 3 (2). ISSN 2381-4683

Angelis, Aris (2016) Why are the prices of new medicines so high and what can we do about it? (F8). European Health Forum Gastein (30 Sep 2016). Website.

Angelis, Aris and Kanavos, Panos (2017) Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework. Social Science and Medicine, 188. pp. 137-156. ISSN 0277-9536

Athanasakis, Kostas, Kyriopoulos, Ilias and Kyriopoulos, John (2018) To switch or not to switch? Patient attitudes towards generic substitution in Greece. Journal of Pharmaceutical Health Services Research, 9 (3). pp. 271-273. ISSN 1759-8885

B

Bakker, Gerben (2010) Book review: Wellcome & co.: knowledge, trust, profit and the transformation of the British pharmaceutical industry, 1880-1940. Medical History, 54 (2). pp. 260-261. ISSN 0025-7273

Banerjee, Sube, Hellier, J, Romer, R, Dewey, M, Knapp, Martin, Ballard, C, Baldwin, Robert, Bentham, Peter, Fox, C., Holmes, Clive, Katona, Cornelius, Livingston, G., Lawton, C, McCrae, N, Moniz-Cook, E, Murray, J, Nurock, J, Orrell, Martin, O'Brien, J, Poppe, M, Thomas, A, Walwyn, R, Wilson, K, Burns, A and Lindesay, James (2013) Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment, 17 (7). ISSN 1366-5278

Beckett, Charlie (2007) MMR, the media and risk. POLIS: journalism and society at the LSE (18 Jul 2007). Blog Entry.

Bergsma, W. P., Aris, E. M. D. and Tibaldi, F. S. (2013) Linear Categorical Marginal Modeling of solicited symptoms in vaccine clinical trials. Statistics in Biopharmaceutical Research, 5 (1). pp. 27-37. ISSN 1946-6315

Beutels, Philippe, Luyten, Jeroen, Lejeune, Olivier, Hens, Niel, Bilcke, Joke, De Schrijver, Koen, Van de Sande, Stefaan, Van Herck, Koen and Van Damme, Pierre (2008) Evaluatie van universele en doelgroep hepatitis A vaccinatie opties in België = Evaluation of universal and targeted hepatitis A vaccination programs in Belgium. KCE reports 98A ((D/2008/10.273/88)). Federaal Kenniscentrum voor de Gezondheidszorg (KCE), Brussels, Belgium.

Bissell, P., Sadler, Stacey, Anderson, Claire and Tinelli, Michela (2005) Community pharmacists’ perceptions and experiences of interprofessional collaboration with general practitioners. In: Health Services Research & Pharmacy Practice Conference, 2005-03-01. (Submitted)

Blenkinsopp, Alison, Bissell, P., Short, D. and Tinelli, Michela (2005) Evaluating patient feedback on a new medicines management service provided by community pharmacists. In: Health Services Research & Pharmacy Practice Conference, 2005-03-01. (Submitted)

Bogacka, Barbara, Patan, Maciej, Johnson, Patrick, J, Youdim, K and Atkinson, Anthony C. (2011) Optimum design of experiments for enzyme inhibition kinetic models. Journal of Biopharmaceutical Statistics, 21 (3). pp. 555-572. ISSN 1054-3406

Bond, C. M., Blenkinsopp, Alison, Bissell, P. and Tinelli, Michela (2004) Evaluation of the Community Pharmacy Medicines Management Project. In: British Pharmaceutical Conference, 2004-09-27 - 2004-09-29. (Submitted)

Bonser, Andrew, Kanavos, Panos and Taylor, David (2016) Tender Loving Care? Purchasing medicines for continuing therapeutic improvement and better health outcomes. . London School of Economics, London, UK.

Bradley, James and Vandoros, Sotiris (2012) Creative compliance in pharmaceutical markets: the case of profit controls. Expert Review of Pharmacoeconomics and Outcomes Research, 12 (1). pp. 31-38. ISSN 1473-7167

C

Cerri, Karin H., Knapp, Martin and Fernandez, Jose-Luis (2013) Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making. European Journal of Health Economics, 15 (7). pp. 681-695. ISSN 1618-7598

Cockburn, Iain, Lanjouw, Jean O. and Schankerman, Mark (2014) Patents and the global diffusion of new drugs. CEP Discussion Papers (CEPDP1298). Centre for Economic Performance, London School of Economics and Political Science, London, UK.

Cohen, Lucía (2013) Pharma online: does regulation or corporate social media policy need to change to allow a real dialogue about medicines? POLIS: journalism and society at the LSE (06 Feb 2013). Blog Entry.

Collins, John (2017) Regulation as global drug governance: how new is the NPS phenomenon? In: Corazza, Ornella and Roman-Urrestarazu, Andres, (eds.) Novel Psychoactive Substances. Springer, Cham, Switzerland, pp. 23-41. ISBN 9783319605999

Cordella, Antonio (2002) Knowledge production vs knowledge management: the case of pharmaceutical R&D. In: EURAM 2nd Annual Conference: Innovative Research in Management, 2002-05-09 - 2002-05-11. (Submitted)

Cordella, Antonio and Grisot, M. (2002) Distributed knowledge across boundaries. In: EURAM 2nd Annual Conference: Innovative Research in Management, 2002-05-09 - 2002-05-11. (Submitted)

Cornford, Tony (2017) The digital future beyond the pill. Delivering Digital Drugs (10 May 2017). Blog Entry.

Cornford, Tony, Savage, Imogen, Jani, Yogini, Franklin, Bryony Dean, Barber, Nick, Slee, Ann and Jacklin, Ann (2010) Learning lessons from electronic prescribing implementations in secondary care. Studies in Health Technology and Informatics, 160. pp. 233-237. ISSN 0926-9630

Costa Font, Joan, Rudisill, Caroline and Stefanie, Tan (2014) How important is patient brand loyalty in the uptake of generic drugs? LSE Health and Social Care (20 Mar 2014). Blog Entry.

Costa-Font, Joan (2016) Deregulation and access to medicines: the Peruvian experience. Journal of International Development, 28 (6). pp. 997-1005. ISSN 0954-1748

Costa-Font, Joan, McGuire, Alistair and Varol, Nebibe (2015) Regulation effects on the adoption of new medicines. Empirical Economics, 49 (3). pp. 1101-1121. ISSN 0377-7332

Costa-i-Font, Joan (2015) Parallel trade in medicinal drugs is putting the welfare of EU patients at risk. LSE European Politics and Policy (EUROPP) Blog (20 Mar 2015). Blog Entry.

Costa-i-Font, Joan, Hernandez-Quevedo, Christina and Sato, Azusa (2013) A 'Health Kuznets' curve'? Cross-country and longitudinal evidence. CESifo working paper (4446). CESifo Group, Munich, Germany.

Costa-i-Font, Joan, Varol, Nebibe and McGuire, Alistair (2011) Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008. CESifo working paper (3441). CESifo Group, Munich, Germany.

Coulter, Steve (2014) The war over drugs: what’s at stake? LSE New European Trade Unions (03 Jun 2014). Blog Entry.

Crea, Giovanni, Galizzi, Matteo M., Linnosmaa, Ismo and Miraldo, Marisa (2019) Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data. Journal of Health Economics, 65. pp. 153-169. ISSN 0167-6296

D

Dickson, Jane (2016) $1 million for a drug used once. Delivering Digital Drugs (10 May 2016). Blog Entry.

Dickson, Jane (2015) 165,000 and counting! Delivering Digital Drugs (16 Oct 2015). Blog Entry.

Dickson, Jane (2015) Books about the future of medicine, digital doctors, patient safety etc. Delivering Digital Drugs (15 Apr 2015). Blog Entry.

Dickson, Jane (2015) D3 Research presents a poster at the LSE Research Festival. Delivering Digital Drugs (29 May 2015). Blog Entry.

Dickson, Jane (2014) The D3 project. Delivering Digital Drugs (07 Apr 2014). Blog Entry.

Dickson, Jane (2015) Digital necklace wins Unicef award. Delivering Digital Drugs (16 Dec 2015). Blog Entry.

Dickson, Jane (2015) E-prescribing and ADE in primary care – data and evidence from meaningful use in the US. Delivering Digital Drugs (14 Sep 2015). Blog Entry.

Dickson, Jane (2015) Enduring and emerging challenges of informed consent. Delivering Digital Drugs (13 Mar 2015). Blog Entry.

Dickson, Jane (2015) Mental health monitoring through ‘selfie’ videos and social media tracking. Delivering Digital Drugs (02 Feb 2015). Blog Entry.

Dickson, Jane (2015) NHS England initiative: ‘combinatorial innovation’ in NHS test beds. Delivering Digital Drugs (27 Mar 2015). Blog Entry.

Dickson, Jane (2015) National systems of patient unique identifiers – nations pro and against. Delivering Digital Drugs (10 Apr 2015). Blog Entry.

Dickson, Jane (2015) Non-adherence to prescriptions is categorical construct. Non-persistence adds a time dimension to it. Delivering Digital Drugs (14 Sep 2015). Blog Entry.

Dickson, Jane (2015) Personalized medicine: a podcast. Delivering Digital Drugs (13 Mar 2015). Blog Entry.

Dickson, Jane (2014) Pharmacogenetics test lab embedded in ePrescribing, for personalised medicine? Delivering Digital Drugs (09 Apr 2014). Blog Entry.

Dickson, Jane (2015) Precision medicine on BBC Radio 4 Today Programme. Delivering Digital Drugs (30 Oct 2015). Blog Entry.

Dickson, Jane (2014) Research hypothesis and objectives. Delivering Digital Drugs (07 Apr 2014). Blog Entry.

Dickson, Jane (2015) Results of latest international action on counterfeit and unlicensed medicines. Delivering Digital Drugs (19 Jun 2015). Blog Entry.

Dickson, Jane (2015) Serialisation of individual pills to defeat counterfeiters. Delivering Digital Drugs (10 Sep 2015). Blog Entry.

Dickson, Jane (2016) Shining a light on Lumosity’s claims. Delivering Digital Drugs (06 Jan 2016). Blog Entry.

Dickson, Jane (2015) Sounds like a diagnosis? Delivering Digital Drugs (28 Jul 2015). Blog Entry.

Dickson, Jane (2015) Stratified medicine in 2015 – Leeds Christmas lecture. Delivering Digital Drugs (19 Dec 2015). Blog Entry.

Dickson, Jane (2015) Tackling the problem of sub-standard therapeutic drugs in Kenya. Delivering Digital Drugs (19 Jun 2015). Blog Entry.

Dickson, Jane (2016) Testing & mental health apps. Delivering Digital Drugs (25 May 2016). Blog Entry.

Dickson, Jane (2015) Type 1 diabetes breakthrough. Delivering Digital Drugs (10 Sep 2015). Blog Entry.

Dickson, Jane (2016) Vita brevis ars longa: feeding Watson on dubious data. Delivering Digital Drugs (08 Mar 2016). Blog Entry.

Dickson, Jane (2017) Vocal biomarkers: diagnostics through human voice. Delivering Digital Drugs (17 Feb 2017). Blog Entry.

Dickson, Jane (2017) Warfarin history timeline. Delivering Digital Drugs (15 May 2017). Blog Entry.

Dickson, Jane (2015) Worrying about data. Delivering Digital Drugs (14 Aug 2015). Blog Entry.

Dickson, Jane (2015) A decision support tool for warfarin prescribing. Delivering Digital Drugs (13 Feb 2015). Blog Entry.

Duffin, Tony (2018) How academics and service providers are working together to inform drug policy in Ireland. LSE European Politics and Policy (EUROPP) Blog (31 Jan 2018). Blog Entry.

Dyke, Heather (2016) Why is doping wrong anyway? LSE Philosophy Blog (17 Aug 2016). Website.

E

Evans-Lacko, Sara and Knapp, Martin (2016) Cost of depression in the workplace across eight diverse countries – collectively US$250 billion. LSE Health and Social Care (15 Nov 2016). Blog Entry.

F

Feick, Jürgen (2005) Learning and interest accommodation in policy and institutional change: EC risk regulation in the pharmaceuticals sector. CARR Discussion Papers (DP 25). Centre for Analysis of Risk and Regulation, London School of Economics and Political Science, London, UK. ISBN 0753017466

Ferrario, Alessandra and Kanavos, Panos (2015) Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science and Medicine, 124. pp. 39-47. ISSN 0277-9536

Ferrario, Alessandra and Kanavos, Panos (2013) Managed entry agreements for pharmaceuticals: the European experience. . EMiNet, Brussels, Belgium.

Ferrario, Alessandra, Sautenkova, Nina, Bezverhni, Zinaida, Seicas, Rita, Habicht, Jarno, Kanavos, Panos and Safta, Vladimir (2014) An in-depth analysis of pharmaceutical regulation in the Republic of Moldova. Journal of Pharmaceutical Policy and Practice, 7 (1). p. 4. ISSN 2052-3211

G

Gandecha, Reshma, Klecun, Ela, Jacklin, Ann and Williams, Simon (2005) What the national IT programme means for pharmacy and pharmacists. Pharmaceutical Journal, 275 (7357). pp. 56-60. ISSN 0031-6873

Gerard, Karen, Tinelli, Michela, Latter, Sue, Blenkinsopp, Alison and Smith, Alesha (2012) Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment. Value in Health, 15 (5). pp. 699-707. ISSN 1098-3015

H

Hibberd, Ralph (2016) Accelerating access to new drugs in Japan. Delivering Digital Drugs (11 May 2016). Blog Entry.

Hibberd, Ralph (2017) Brexit and the falsified medicines directive. Delivering Digital Drugs (17 Feb 2017). Blog Entry.

Hibberd, Ralph (2016) Combating falsified medicines in Africa through digital artefacts. Delivering Digital Drugs (27 Sep 2016). Blog Entry.

Hibberd, Ralph (2016) Hub and spoke dispensing: privacy and sociotechnical rigidity. Delivering Digital Drugs (08 Jul 2016). Blog Entry.

Hibberd, Ralph (2016) Hub and spoke dispensing: safety and sociotechnical pliability. Delivering Digital Drugs (07 Jul 2016). Blog Entry.

Hibberd, Ralph, Barber, Nick, Cornford, Tony and Lichtner, Valentina (2012) The evaluation of the electronic prescription service in primary care: interim report on the findings from the evaluation in early implementer sites. . University College London, London, UK.

Hong, Jihyung, Reed, Catherine, Novick, Diego, Haro, Josep Maria and Aguado, Jaume (2011) Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study. Psychiatry Research, 190 (1). pp. 110-114. ISSN 0165-1781

Howard, Robert, McShane, Rupert, Lindesay, James, Ritchie, Craig, Baldwin, Ashley, Barber, Robert, Burns, Alistair, Dening, Tom, Findlay, David, Holmes, Clive, Jones, Robert, Jones, Roy, McKeith, Ian, Macharouthu, Ajay, O'Brien, John, Sheehan, Bart, Juszczak, Edmund, Katona, Cornelius, Hills, Robert, Knapp, Martin, Ballard, Clive, Brown, Richard G, Banerjee, Sube, Adams, Jessica, Johnson, Tony, Bentham, Peter and Phillips, Patrick P J (2015) Nursing home placement in the Donepezil and Memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses. The Lancet Neurology, 14 (12). pp. 1171-1181. ISSN 1474-4422

Hughes, Diana, Waddingham, Ed, A., J., Mt-Isa, Shahrul, Goginsky, Alesia, Chan, Edmond, Downey, Gerald, Hallgreen, Christine E., Hockley, Kimberley S., Juhaeri, Juhaeri, Lieftucht, Alfons, Metcalfe, Marilyn, A., Noel, Rebecca, A., Phillips, Lawrence D., Ashby, Deborah and Micaleff, Alain (2014) IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines. . PROTECT Consortium, London.

I

Ikeda, S., Ikegami, N., Oliver, Adam and Ikeda, M. (1996) A case for the adoption of pharmacoeconomic guidelines in Japan. PharmacoEconomics, 10. pp. 546-551. ISSN 1170-7690

J

Jackson, Emily, Feldschreiber, P and Breckenridge, A (2017) Regulatory consequences of “Brexit” for the development of medicinal products. Clinical Pharmacology and Therapeutics, 102. pp. 183-184. ISSN 0009-9236

Jackson, N., Atar, D., Borentain, M., Breithardt, G., van Eickels, M., Endres, M., Fraass, U., Friede, T., Hannachi, H., Janmohamed, S., Kreuzer, J., Landray, M., Lautsch, D., Le Floch, C., Mol, P., Naci, H., Samani, N. J., Svensson, A., Thorstensen, C., Tijssen, J., Vandzhura, V., Zalewski, A. and Kirchhof, P. (2015) Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. European Heart Journal. ISSN 0195-668X

Jaffray, Mariesha, Bond, Christine and Tinelli, Michela (2005) The Community Pharmacy Medicines Management Project: final report. . University of Aderdeen, Keele University, University of Nottingham, The College of Pharmacy Practice, UK.

Jaffray, Mariesha, Bond, Christine M., Watson, M. C., Hannaford, Philip, Tinelli, Michela, Scott, A., Lee, A., Blenkinsopp, Alison, Anderson, Cameron, Avery, Anthony, Bissell, P. and Krksa, J. (2007) The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Family Practice, 24 (2). pp. 189-200. ISSN 0263-2136

Jiménez Rubio, Dolores and Hernández-Quevedo, Cristina (2010) Spain: the effect of country of birth on patterns of pharmaceutical use. Eurohealth, 16 (4). pp. 18-19. ISSN 1356-1030

K

Kalbfuß, Jörg, Odermatt, Reto and Stutzer, Alois (2018) Medical marijuana laws and mental health in the United States. CEP Discussion Papers (CEPDP1546). Centre for Economic Performance, London School of Economics and Political Science, London, UK.

Kanavos, Panos (1999) Financing pharmaceuticals in transition. Croatian Medical Journal, 40 (June). pp. 244-259. ISSN 0353-9504

Kanavos, Panos (2001) Overview of pharmaceutical pricing and reimbursement regulation. . LSE Health, London, U.K..

Kanavos, Panos and Angelis, Aris (2014) Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1? Pharmaceutical Medicine, online. ISSN 1178-2595

Kanavos, Panos, Angelis, Aris and Drummond, Michael (2019) An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed? European Journal of Health Economics, 20 (3). pp. 329-332. ISSN 1618-7598

Kanavos, Panos and Mossialos, Elias (1999) Outstanding regulatory issues in the European Union pharmaceutical market. PharmacoEconomics, 15 (6). pp. 519-533. ISSN 1170-7690

Kanavos, Panos and Nicod, Elena (2012) What is wrong with orphan drug policies?: suggestions for ways forward. Value in Health, 15 (8). pp. 1182-1184. ISSN 1098-3015

Kanavos, Panos, Vandoros, Sotiris, Irwin, Rachel, Nicod, Elena and Casson, Margaret (2011) Differences in costs of and access to pharmaceutical products in the EU. . European Parliament, Brussels. (Submitted)

Kanavos, Panos, Vandoros, Sotiris, Irwin, Rachel, Nicod, Elena and Casson, Margaret (2010) The European pharmaceutical market and policies - outlook for the future. . European Parliament, Brussels, Belgium.

Kanavos, Panos and Wouters, Olivier J. (2014) Competition issues in the distribution of pharmaceuticals. In: OECD Global Forum on Competition, 2014-02-27 - 2014-02-28.

Kanavos, Panos and Wouters, Olivier J. (2014) Concurrence dans la distribution de produits pharmaceutiques. In: OECD Forum Mondial sur la Concurrence, 2014-02-27 - 2014-02-28.

Kanavos, Panos G. and Vandoros, Sotiris (2011) Determinants of branded prescription medicine prices in OECD countries. Health Economics, Policy and Law, 6 (3). pp. 1-31. ISSN 1744-1331

Kawalec, Paweł, Sagan, Anna and Pilc, Andrzej (2016) The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe. Orphanet Journal of Rare Diseases, 11 (122). ISSN 1750-1172

Kravdal, Øystein, Grundy, Emily and Skirbekk, Vegard (2017) Fertility history and use of antidepressant medication in late mid-life: a register-based analysis of Norwegian women and men. Aging and Mental Health, 21 (5). pp. 477-486. ISSN 1360-7863

L

Levitan, Bennett, Phillips, Lawrence D. and Walker, Stuart (2014) Structured approaches to benefit-risk assessment: a case study and the patient perspective. Therapeutic Innovation and Regulatory Science, 48 (5). pp. 564-573. ISSN 2168-4790

Lewer, D., O'Reilly, C., Mojtabai, R. and Evans-Lacko, S. (2015) Antidepressant use in 27 European countries: associations with sociodemographic, cultural and economic factors. British Journal of Psychiatry, 207 (3). pp. 221-226. ISSN 0007-1250

Lichtner, Valentina (2016) ‘the little liar’ – patient information about medicines. Delivering Digital Drugs (10 May 2016). Blog Entry.

Liebenau, Jonathan (2013) Modernising the business of health: pharmaceuticals in Britain, in comparison with Germany and the United States, 1890-1940. Industrial and Corporate Change, 22 (3). pp. 807-847. ISSN 0960-6491

Luciano, Juan V., D’Amico, Francesco, Cerdà-Lafont, Marta, Peñarrubia-María, María T., Knapp, Martin, Cuesta-Vargas, Antonio I., Serrano-Blanco, Antoni and García-Campayo, Javier (2014) Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Arthritis Research and Therapy, 16 (5). p. 451. ISSN 1478-6354

Luyten, Jeroen and Beutels, Philippe (2009) Costing infectious disease outbreaks for economic evaluation. PharmacoEconomics, 27 (5). pp. 379-389. ISSN 1170-7690

Luyten, Jeroen, Desmet, Pieter, Dorgali, Veronica, Hens, Niel and Beutels, Philippe (2014) Kicking against the pricks: vaccine sceptics have a different social orientation. European Journal of Public Health, 24 (2). pp. 310-314. ISSN 1101-1262

Luyten, Jeroen, Dorgali, Veronica, Hens, Niel and Beutels, Philippe (2013) Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study. Social Science and Medicine, 77. pp. 84-89. ISSN 0277-9536

Luyten, Jeroen, Marais, Christiaan, Hens, Niel, De Schrijver, Koen and Beutels, Philippe (2011) Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis A patients. Value in Health, 14 (2). pp. 282-290. ISSN 1098-3015

Luyten, Jeroen, Van de Sande, Stefaan, De Schrijver, Koen, Van Damme, Pierre and Beutels, Philippe (2012) Cost-effectiveness of hepatitis A vaccination for adults in Belgium. Vaccine, 30 (42). pp. 6070-6080. ISSN 0264-410X

Luyten, Jeroen, Vandevelde, Antoon, Van Damme, Pierre and Beutels, Philippe (2011) Vaccination policy and ethical challenges posed by herd immunity, suboptimal uptake and subgroup targeting. Public Health Ethics, 4 (3). pp. 280-291. ISSN 1754-9973

M

Manfrin, Andrea, Knapp, Martin, Cicchetti, Americo, Mandelli, Andrea and Tinelli, Michela (2018) VP164 Applying health technology assessment to pharmacy: the Italian-Medicine-Use-Review-Health Technology Assessment. International Journal of Technology Assessment in Health Care, 33 (S1). ISSN 0266-4623

Matheson, Catriona, Bond, C. and Tinelli, Michela (2006) Community pharmacists and drug misusers: national trends in attitudes and current practice. In: British Pharmaceutical Conference, 2006-09-04 - 2006-09-06. (Submitted)

Maynou-Pujolras, Laia and Cairns, John (2015) Why do some countries approve a cancer drug and others don't? Journal of Cancer Policy, 4. pp. 21-25. ISSN 2213-5383

Micaleff, Alain, Callreus, Tornbjorn, Phillips, Lawrence D., Hughes, Diana, Hockley, Kimberley, Wang, Nan and Luciani, David (2013) IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab). . PROTECT Consortium, London.

Morais de Oliveira, Iago (2016) Using international human rights law to guarantee the right to health: a Brazilian experience. LSE Human Rights Blog (13 Dec 2016). Blog Entry.

Mossialos, Elias, Courtin, Emilie, Naci, Huseyin, Benrimoj, Shalom, Bouvy, Marcel, Farris, Karen, Noyce, Peter and Sketris, Ingrid (2015) From "retailers" to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy, 119 (5). pp. 628-639. ISSN 0168-8510

Mossialos, Elias, Ge, Yanfeng, Hu, Jia and Wang, Liejun (2016) Building a strong pharmaceutical system for China. LSE Health and Social Care (07 Jul 2016). Blog Entry.

Mossialos, Elias, Kanavos, Panos and Abel-Smith, B. (1994) Policy options for pharmaceutical research and development in the European Community. Science and Technology Options Assessment Programme. European Parliament, Brussels, Belgium.

Mossialos, Elias and Mrazek, Monique F. (2003) The regulation of pharmacies in six countries: report prepared for the Office of Fair Trading. . Office of Fair Trading, London, UK.

Mossialos, Elias and Srivastava, Divya (2008) Pharmaceutical policies in Finland - challenges and opportunities. Observatory Studies Series (10). World Health Organization, Copenhagen, Denmark.

Mt-Isa, Shahrul, Hallgreen, Christine E., Wang, Nan, Callréus, Torbjörn, Genov, Georgy, Hirsch, Ian, Hobbiger, Stephen F., Hockley, Kimberley S., Luciani, Davide, Phillips, Lawrence D., Quartey, George, Sarac, Sinan B., Stoeckert, Isabelle, Tzoulaki, Ioanna, Micaleff, Alain and Ashby, Deborah (2014) Balancing benefit and risk of medicines: a systematic review and classification of available methodologies. Pharmacoepidemiology and Drug Safety, 23 (7). pp. 667-678. ISSN 1053-8569

Mt-Isa, Shahrul, Hallgreen, Christine, E., Asiimwe, Alex, Downey, Gerry, Genov, Georgy, Hermann, Richard, Hughes, Diana, Lieftucht, Alfons, Noel, Rebecca, Peters, Ruth, Phillips, Lawrence D., Shepherd, Susan, Micaleff, Alain, Ashby, Deborah and Tzoulak, Ioanna (2013) Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: stage 2 of 2. . PROTECT Consortium, London.

Mt-Isa, Shahrul, Peters, Ruth, Phillips, Lawrence D., Chan, Kakit, Hockley, Kimberley S., Wang, Nan, Ashby, Deborah and Tzoulak, Ioanna (2013) Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: Stage 1 of 2. . PROTECT Consortium, London.

Mwita, Stanley, Jande, Mary, Marwa, Karol, Hamasaki, Kayo, Katabalo, Deogratius, Burger, Johanita, Godman, Brian, Ferrario, Alessandra, Massele, Amos and Ruganuza, Deodatus (2017) Medicines dispensers' knowledge on the implementation of an artemisinin-based combination therapy policy for the treatment of uncomplicated malaria in Tanzania. Journal of Pharmaceutical Health Services Research. ISSN 1759-8885

N

Naci, Huseyin, Carter, Alexander W. and Mossialos, Elias (2015) Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector. BMJ. ISSN 1756-1833

Naci, Huseyin, Carter, Alexander W. and Mossialos, Elias (2015) Why the drug development pipeline is not delivering better medicines. BMJ, 351. ISSN 1756-1833

Naci, Huseyin, Wouters, Olivier J., Gupta, Radhika and Ioannidis, John P. A. (2017) Timing and characteristics of cumulative evidence available on novel therapeutic agents receiving Food and Drug Administration accelerated approval. Milbank Quarterly, 95 (2). pp. 261-290. ISSN 0887-378X

Nicod, Elena, Annemans, Lieven, Bucsics, Anna, Lee, Anne, Upadhyaya, Sheela and Facey, Karen (2017) HTA programme response to the challenges of dealing with orphan medicinal products: process evaluation in selected European countries. Health Policy. ISSN 0168-8510

O

Olczak, Kaya, Salcher, Maximillian and Naci, Huseyin (2016) What works best in congenital heart disease? Comparing two interventions for treatment of Aortic Coarctation. LSE Health and Social Care (02 Sep 2016). Blog Entry.

Oliver, Adam, Ikegami, N. and Ikeda, S. (1999) The Japanese government's pharmaceutical policy and its effect on hospital financial viability. Journal of Health Services Research and Policy, 4. pp. 27-32. ISSN 1355-8196

P

Pan, Yi-Ju, Knapp, Martin and McCrone, Paul R. (2012) Cost-effectiveness comparisons between antidepressant treatments in depression: evidence from database analyses and prospective studies. Journal of Affective Disorders, 139 (2). pp. 113-125. ISSN 0165-0327

Permanand, Govin and Altenstetter, Christa (2004) The politics of the EU pharmaceutical industry. In: Mossialos, Elias, Mrazek, Monique and Walley, Tom, (eds.) Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. Open University Press, Maidenhead, pp. 38-54. ISBN 0335214657

Permanand, Govin and Mossialos, Elias (2004) Theorising the development of the European Union framework for pharmaceutical regulation. . LSE Health and Social Care, London, U.K..

Phillips, Lawrence D. (2013) Benefit-risk modeling of medicinal products: methods and applications. In: Sashegyi, Andreas, Felli, James and Noel, Rebecca, (eds.) Benefit-Risk Assessment in Pharmaceutical Research and Development. CRC Press, Boca Raton, pp. 59-96. ISBN 9781439867945

Phillips, Lawrence D., Amzal, Billy, Asiimwe, Alex, Chan, Edmond, Chen, Chen, Hughes, Diana, Juhaeri, Juhaeri, Micaleff, Alain, Mt-Isa, Shahrul, Noel, Becky, Shepherd, Susan and Wang, Nan (2013) IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone. . PROTECT Consortium, London.

Phillips, Lawrence D., Fasolo, Barbara, Zafiropoulos, Nikolaos and Beyer, Andrea (2011) Is quantitative benefit–risk modelling of drugs desirable or possible? Drug Discovery Today: Technologies, 8 (1). e3-e10. ISSN 1740-6749

Phillips, Lawrence D., and et al., (2014) Benefit-risk methodology project:update on work package 5: effects table pilot (phase I). . European Medicines Agency, London.

Phillips, Lawrence D., and et al., (2011) Benefit-risk methodology project:work package 1 report: description of the current practice of benefit-risk assessment for centralised procedure products in the EU regulatory network. . European Medicines Agency, London.

Phillips, Lawrence D., and et al., (2011) Benefit-risk methodology project:work package 2 report: applicability of current tools and processes for regulatory benefit-risk assessment. . European Medicines Agency, London.

Phillips, Lawrence D., and et al., (2011) Benefit-risk methodology project:work package 3 report: field tests. . European Medicines Agency, London.

Phillips, Lawrence D., and et al., (2012) Benefit-risk methodology project:work package 4 report: benefit-risk tools and processes. . European Medicines Agency, London.

R

Relle, Katherine (2013) Why social media is good for medicine and why pharmaceutical companies should engage online. POLIS: journalism and society at the LSE (28 Jan 2013). Blog Entry.

Renewick, Matthew, Simpkin, Victoria and Mossialos, Elias (2016) Targeting innovation in antibiotics. LSE Health and Social Care (01 Jul 2016). Blog Entry.

Renwick, Mathew and Mossialos, Elias (2018) What are the economic barriers of antibiotic R&D and how can we overcome them? Expert Opinion on Drug Discovery, 13 (10). pp. 889-892. ISSN 1746-0441

S

Sadler, Stacey, Bissell, P., Anderson, Claire, Avery, Anthony and Tinelli, Michela (2005) General Practitioners’ perceptions of interprofessional collaboration with community pharmacists. In: Health Services Research & Pharmacy Practice Conference, 2005-03-01. (Submitted)

Salas-Vega, Sebastian, Bertling, Annika and Mossialos, Elias (2016) A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK. Health Policy, 120 (10). pp. 1104-1114. ISSN 0168-8510

Sampat, Bhaven N. and Shadlen, Kenneth C. (2015) Drug patenting in India: looking back andlooking forward. Nature Reviews: Drug Discovery, 14. pp. 519-520. ISSN 1474-1776

Sampat, Bhaven N., Shadlen, Kenneth C. and Amin, Tahir M. (2012) Challenges to India's pharmaceutical patent laws. Science, 337 (6093). pp. 414-415. ISSN 0036-8075

Serra-Sastre, Victoria and McGuire, Alistair (2013) Information and diffusion of new prescription drugs. Applied Economics, 45 (15). pp. 2049-2057. ISSN 0003-6846

Shadlen, Kenneth C. (2016) Debating Patents and Drug Prices: Trade Agreements and the Trans-Pacific Partnership. International Development (02 Nov 2016). Blog Entry.

Shadlen, Kenneth C. (2013) Learning from India? A new approach to secondary pharmaceutical patents. South Asia @ LSE (03 May 2013). Blog Entry.

Shadlen, Kenneth C. (2011) The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in Brazil. Politics and Society, 39 (2). pp. 143-174. ISSN 0032-3292

Shadlen, Kenneth C. (2011) The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies. In: Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka and Lalitha, N., (eds.) Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries. Edward Elgar Publishing, pp. 178-201. ISBN 9781849800143

Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka and Lalitha, N. (2011) Globalization, intellectual property rights, and pharmaceuticals: meeting the challenges to addressing health gaps in the new international environment. In: Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka and Lalitha, N., (eds.) Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries. Edward Elgar Publishing, pp. 1-28. ISBN 9781849800143

Shadlen, Kenneth C. and Sampat, Bhaven N. (2015) Drug patenting in India: looking back and looking forward. South Asia @ LSE (09 Nov 2015). Blog Entry.

Shadlen, Kenneth C. and Sampat, Bhaven N. (2018) Indian pharmaceutical patent prosecution: the changing role of Section 3(d). PLOS ONE, 13 (4). ISSN 1932-6203

Shadlen, Kenneth C., Sampat, Bhaven N. and Amin, Tahir M. (2012) Balancing innovation and access: India’s pharmaceutical patent laws. South Asia @ LSE (23 Jul 2012). Blog Entry.

Shadlen, Kenneth C., Sampat, Bhaven N. and Kapczynski, Amy (2019) Patents, trade, and medicines: past, present, and future. Review of International Political Economy. ISSN 0969-2290

Simpkin, Victoria, Namubiru-Mwaura, Evelyn, Clarke, Lorcan and Mossialos, Elias (2019) Investing in health R&D: where we are, what limits us, and how to make progress in Africa. BMJ Global Health, 4 (2). ISSN 2059-7908

Sosa, M. Lourdes (2009) Application-specific R&D capabilities and the advantage of incumbents: evidence from the anticancer drug market. Management Science, 55 (8). pp. 1409-1422. ISSN 0025-1909

Sosa, M. Lourdes (2013) Decoupling market incumbency from organizational prehistory: locating the real sources of competitive advantage in R&D for radical innovation. Strategic Management Journal, 34 (2). pp. 245-255. ISSN 0143-2095

Srivastava, Divya and McGuire, Alistair (2014) Analysis of prices paid by low-income countries: how price sensitive is government demand for medicines? BMC Public Health, 14 (1). p. 767. ISSN 1471-2458

T

Thambisetty, Sivaramjani (2013) Compulsory licenses for pharmaceuticals: an inconvenient truth? India at LSE (25 Mar 2013). Blog Entry.

Thambisetty, Sivaramjani (2018) Improving access to patented medicines: are human rights getting in the way? LSE Law, Society and Economy Working Papers (3/2018). London School of Economics and Political Science, Department of Law, London, UK.

Thambisetty, Sivaramjani (2013) Novartis v Union of India and the person skilled in the art: a missed opportunity. . London School of Economics and Political Science ; Social Sciences Research Network, London, UK.

Thambisetty, Sivaramjani (2014) Novartis v Union of India and the person skilled in the art: a missed opportunity. Queen Mary Journal of Intellectual Property, 4 (1). pp. 79-94. ISSN 2045-9807

Tinelli, Michela (2017) Better outcomes for the patient, the provider and the society now: this is not a dream, and the pharmacist could help! BMJ. ISSN 1756-1833

Tinelli, Michela (2002) Costi dell’aterosclerosi. Farmacoeconomia News, 2. pp. 27-51. ISSN 1126-4705

Tinelli, Michela (2007) Developing and applying discrete choice experiments (DCEs) to inform pharmacy policy. Doctoral thesis, University of Aberdeen.

Tinelli, Michela (2002) Neuropatie diabetiche ed L-carnitina: nuove prospettive di trattamento. Farmacoeconomia News, 3. ISSN 1126-4705

Tinelli, Michela, Bissell, Paul, Blenkinsopp, Alison, Short, Duncan and Mason, Linda (2008) Patients’ experiences of a community pharmacy-led medicines management service. Health and Social Care in the Community, 16 (4). pp. 363-369. ISSN 0966-0410

Tinelli, Michela, Blenkinsopp, Alison, Latter, Sue, Smith, Alesha and Chapman, Stephen R. (2015) Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care. Health Expectations, 18 (5). pp. 1241-1255. ISSN 1369-6513

Tinelli, Michela, Bond, C., Watson, M., Dinnie, L. and Jaffray, Mariesha (2004) Community pharmacists’ attitudes and knowledge of medicines management. In: British Pharmaceutical Conference, 2004-09-27 - 2004-09-29. (Submitted)

Tinelli, Michela, Jaffray, M, Krksa, J. and Bond, Christine M. (2007) The MEDMAN project: evaluation of the medicines management training for community pharmacists. Pharmacy Education, 7 (3). pp. 207-214. ISSN 1560-2214

Tinelli, Michela, Jaffray, M., Bond, C. and Watson, M. C. (2005) Practice staff’s views on a community pharmacy-led medicines management service. In: Health Services Research & Pharmacy Practice Conference, 2005-03-01. (Submitted)

Tinelli, Michela, Jaffray, M., Bond, C. and Watson, M. C. (2005) What patients want from a pharmacy-led medicines management service. In: Health Services Research & Pharmacy Practice Conference, 2005-03-01. (Submitted)

Tinelli, Michela, Krska, J. and Avery, A. J. (2008) Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. British Journal of Clinical Pharmacology, 65 (3). pp. 386-396. ISSN 0306-5251

Tinelli, Michela, Manfrin, Andrea, Knapp, Martin and Mandelli, A. (2017) VP164: Applying HTA to pharmacy: the Italian-Medicine-Use-Review-HTA. In: HTAi 2017 Annual Meeting, 2017-06-17 - 2017-06-21. (Submitted)

Tinelli, Michela, Ryan, M. and Bond, Christine (2007) Economic evaluation advancement in pharmacy: discrete choice experiments (DCEs). International Journal of Pharmacy Practice, 15 (s1). ISSN 0961-7671

Tinelli, Michela, Ryan, M. and Bond, Christine (2010) Session 1A: methods. Discrete choice experiments (DCEs) to inform pharmacy policy: going beyond Quality Adjusted Life Years (QALYs). International Journal of Pharmacy Practice, 18 (S). pp. 1-4. ISSN 0961-7671

Tinelli, Michela, Ryan, Mandy and Bond, Christine (2006) Patient-centred approach to policy development: a pharmacy-led medicines management service. International Journal of Pharmacy Practice, 14 (S). pp. 71-72. ISSN 0961-7671

Tinelli, Michela, Watson, M. C., Bond, C. and Jaffray, M. (2005) General Practitioners’ opinions of and attitudes towards a community pharmacist-led medicines management service for patients with coronary heart disease. In: Society for Academic Primary Care AGM, 2005-01-01. (Submitted)

Tinelli, Michela, White, John and Manfrin, Andrea (2018) Novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider. BMJ Open Respiratory Research, 5 (1). e000322. ISSN 2052-4439

V

Vandoros, Sotiris and Kanavos, Panos (2014) Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union. World Economy, 37 (6). pp. 856-880. ISSN 0378-5920

Varol, Nebibe, Costa-i-Font, Joan and McGuire, Alistair (2010) Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment? LSE Health working papers (19/2010). LSE Health, London School of Economics and Political Science, London, UK. ISBN 9780853284604

Vazza, Lucilla (2016) In Italy primary care prescriptions all electronic from 1 March 2016. Delivering Digital Drugs (28 Feb 2016). Blog Entry.

Vogler, Sabine, Zimmermann, Nina, Ferrario, Alessandra, Wirtz, Veronika J and Babar, Zaheer-Ud-Din (2015) Challenges and opportunities for pharmaceutical pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice, 8 (Suppl). ISSN 2052-3211

Vogler, Sabine, Zimmermann, Nina, Ferrario, Alessandra, Wirtz, Veronika J., de Joncheere, Kees, Bak Pedersen, Hanne, Dedet, Guillaume, Paris, Valérie, Mantel-Teeuwisse, Aukje K. and Babar, Zaheer-Ud-Din (2016) Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. Journal of Pharmaceutical Policy and Practice, 9 (9). ISSN 2052-3211

Von der Schulenburg, Fritz, Vandoros, Sotiris and Kanavos, Panos (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Economics Review, 1 (1). pp. 1-8. ISSN 2191-1991

van Amsterdam, Jan, Phillips, Lawrence D., Henderson, Graeme, Bell, James, Bowden-Jones, Owen, Hammersley, Richard, Ramsey, John, Taylor, Polly, Dale-Perera, Annette, Melichar, Jan, van den Brink, Wim and Nutt, David (2015) Ranking the harm of non-medically used prescription opioids in the UK. Regulatory Toxicology and Pharmacology, 73 (3). pp. 999-1004. ISSN 0273-2300

W

Wallis, Patrick (2000) The first English histories of pharmacy - their origins and influences. Pharmacy in History, 42 (1). pp. 36-46. ISSN 0031-7047

Williams, Thomas Christie (2017) Long read review: drug dealer, MD: how doctors were duped, patients got hooked and why it’s so hard to stop by Anna Lembke. LSE Review of Books (22 Mar 2017). Blog Entry.

Wilson, Leslie, Turkistani, Fatema A., Huang, Wei, Tran, Dang M. and Kuo Lin, Tracy (2018) The impact of alternative pricing methods for drugs in California Workers’ Compensation System: fee-schedule pricing. PLOS ONE, 13 (5). e0197449. ISSN 1932-6203

Wouters, Olivier J. and Kanavos, Panos G. (2015) Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization, 93 (9). pp. 606-613. ISSN 0042-9686

Wouters, Olivier J. and Kanavos, Panos G. (2017) A comparison of generic drug prices in seven European countries: a methodological analysis. BMC Health Services Research, 17 (242). pp. 1-7. ISSN 1472-6963

Z

Zafiropoulos, Nikolaos, Phillips, Lawrence D., Pignatti, Francesco and Luria, Xavier (2012) Evaluating benefit-risk: an Agency perspective. Regulatory Rapporteur, 9 (6). pp. 5-8. ISSN 1742-8955

This list was generated on Thu Jul 18 01:26:59 2019 BST.